Once Daily Valacyclovir for Reducing Viral Shedding in Subjects Newly Diagnosed with Genital Herpes
Objective. Genital herpes (GH) recurrences and viral shedding are more frequent in the first year after initial HSV-2 infection. The objective of this study was to provide the first evaluation of valacyclovir 1 g once daily compared to placebo in reducing viral shedding in subjects newly diagnosed w...
Saved in:
Main Authors: | Mark G. Martens (Author), Kenneth H. Fife (Author), Peter A. Leone (Author), Lynn P. Dix (Author), Clare A. Brennan (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2009-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Valacyclovir in the Management of Recurrent Intraoral Herpes Infection
by: Manuel Dwiyanto Hardjo Lugito, et al.
Published: (2014) -
Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir
by: Polansky H, et al.
Published: (2016) -
Imiquimod in Association With Valacyclovir for Refractory Verrucous Perianal Herpes in an AIDS Patient
by: S. Antunes-Duarte, et al.
Published: (2024) -
Modern aspects of tactics in the genital herpes viral infection (literature review)
by: T Yu Pestrikova, et al.
Published: (2018) -
Asymptomatic shedding of herpes simplex virus in oral cavity
by: Abhay Kulkarni, et al.
Published: (2021)